Sökning: "S100B"
Visar resultat 11 - 15 av 32 avhandlingar innehållade ordet S100B.
11. Health symptoms and potential effects on the blood-brain and blood-cerebrospinal fluid barriers associated with use of wireless telephones
Sammanfattning : Recent years have seen a rapid increase in the use of wireless telephones, yet little systematic data exist on the actual use of such devices in the general population. Mobile and cordless telephones emit radiofrequency fields (RF) raising concern about possible adverse health effects. LÄS MER
12. Management of thoracoabdominal aortic aneurysms and dissections : with emphasis on spinal cord protection in aneurysm repair and non-surgical treatment of type-B dissection
Sammanfattning : Thoraco-abdominal aortic aneurysms and dissections are two very serious disease processes which entail a high risk of vessel rupture and death. Their specific treatment strategies have several similarities which have formed a base for this thesis. LÄS MER
13. Heparin coating and cardiotomy suction in cardiopulmonary bypass
Sammanfattning : The present thesis addresses various means of reducing inflammatory responses associated with cardiopulmonary bypass (CPB) and retransfusion of pericardial suction blood (PSB) during cardiac surgery. Four (I-IV) prospective randomised controlled clinical trials comprising 475 patients were performed in the following areas: effects of heparin coating on measures of clinical outcome and memory function (I, II), inflammatory reactions in PSB and its systemic effects after retransfusion using cardiotomy suction or cell salvage (III) and effects of retransfusion of PSB on memory function and release patterns of protein S100B (IV). LÄS MER
14. On biomarkers in traumatic brain injury
Sammanfattning : Traumatic brain injury (TBI) is a common cause of death and disability. Unfortunately, TBI patients will be affected by secondary insults, such as hypoxia and increased intracranial pressure, which may lead to secondary brain injuries. LÄS MER
15. Checkpoint inhibitor-induced adverse events in the CNS - T-cell characteristics and biomarkers
Sammanfattning : Immune checkpoint inhibitors (ICI) activate T cells to kill cancer cells by blocking inhibitory receptors PD-1 (nivolumab; nivo) or CTLA-4 (ipilimumab; ipi). Activated T cells can also attack any healthy organ, causing unpredictable immune related adverse events (irAE). The risk of irAE is highest when treating with ipi and nivo simultaneously. LÄS MER